Credit Suisse’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,650
Closed -$509K 3070
2023
Q3
$509K Buy
+25,650
New +$486K ﹤0.01% 2679

Other funds holding BTAL

Credit Suisse's BTAL Position: Q4 2023 in Review

Credit Suisse sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 25,650 shares — an estimated $509K sold.

Credit Suisse first reported a position in BTAL in Q3 2023 and held it in 1 quarter. The position peaked at $509K in Q3 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.

  • Credit Suisse reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 25,650 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $509K.
  • Credit Suisse first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and held it in 1 quarter.
  • Credit Suisse's AGF US Market Neutral Anti-Beta Fund position peaked at $509K in Q3 2023.
  • 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.